The Pfizer–Astellas Independent Medical Education Grant for Guideline-Concordant Care and New Data in Muscle-Invasive Bladder Cancer (MIBC) through locally advanced or metastatic urothelial carcinoma (la/mUC) supports independent educational initiatives that address knowledge and practice gaps in the rapidly evolving bladder cancer treatment landscape.
The program focuses on helping healthcare professionals apply new and existing evidence to optimize care for patients with MIBC and la/mUC, including guideline-recommended first-line treatment, perioperative therapies, adverse-event management, multidisciplinary care, and shared decision-making. The program is limited to projects in the United States.
Eligibility Criteria
- Applicant organizations must be based in the United States.
- Eligible applicants include medical, nursing, allied health, and/or pharmacy professional schools.
- Healthcare institutions, including large and small institutions, may apply.
- Only organizations are eligible to receive grants; individuals and independent medical practice groups are not eligible.
- The applicant must be the project/program lead or an authorized designee.
- The project/program lead must be an employee or contractor of the requesting organization.
- The requesting organization must be legally able to receive funding directly from Pfizer Inc.
Funding Details
- Funding range: $10,000–$230,000 per project
- Maximum award: $230,000
- Estimated total RFP budget: $900,000
- Project duration: 18–24 months
Deadline
- Application Deadline: November 10, 2026, at 11:59 PM ET
- RFP release date: September 30, 2026
- Anticipated grant notification: November 30, 2026Anticipated project start: February 2027
- Anticipated project end: July 2028
Further Information
- Applications must be submitted through Pfizer’s MARCIE grant management system.
- Applicants must complete all required sections of the online application and upload the proposal in the designated Proposal/Protocol field.
- For the official Pfizer competitive grants program and current oncology RFPs: Pfizer Competitive Grants Program
- To submit an application through Pfizer’s grant management portal: Pfizer Grant Requester Portal